In the Life Sciences industry, many drugs on the market today have been approved for indications for which they were not originally developed. Sometimes, discovering a new use for a drug happens by chance during a clinical trial or post-market, as more information is learned about the drug’s effects that weren’t originally …
Being FAIR with Your Data Set-Up: The New Essential Practice for Life Science Companies to Extend the Value of their Science
There’s a growing understanding among smart life science organizations that their investments in their scientific data can’t be based on a one-and-done approach, where research data is set up for one goal, then discarded afterward. There’s too much future value in reusing the data for other important purposes. This is becoming especially …
Creating Organizational Resiliency Through a Dynamic, ROI-based Information Management Strategy – Part 3
In this installment we will discuss processes and policies for an information management strategy. We will focus on Data Governance aspects that are especially critical in the Life Sciences industry. When we govern data, we are interested in the following aspects for managing data: Identifying the single source of truth for all …
